Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatocyte Growth Factor to Improve Functioning in Peripheral Artery Disease: The HI-PAD Study

NCT03363165 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03363165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03363165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatocyte Growth Factor to Improve Functioning in Peripheral Artery Disease: The HI-PAD Study
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2018
Completion date
September 5, 2023
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease